Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection

@article{Yin2017KnockdownOM,
  title={Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection},
  author={Haiyan Yin and Shuwen Song and Xudong Pan},
  journal={Journal of Inflammation (London, England)},
  year={2017},
  volume={14},
  url={https://api.semanticscholar.org/CorpusID:4549482}
}
Knockdown of miR-155 protected mouse microglia BV2 cells from LPS-induced inflammatory injury via targeting RACK1 and deactivating MAPK/NF-κB and mTOR signaling pathways.
View on Springer Nature
journal-inflammation.biomedcentral.com
42 Citations
Highly Influential Citations
1
Background Citations
11
Results Citations
1

42 Citations

miR-155 mediates inflammatory injury of hippocampal neuronal cells via the activation of microglia

It is suggested that miR-155 mediated the inflammatory injury in hippocampal neuronal cells by activating the microglial cells and may be an effective target for TRD therapies.

MiR-200c-3p inhibits LPS-induced M1 polarization of BV2 cells by targeting RIP2

Investigation of the role of miR-200c-3p in regulating inflammatory responses of LPS-treated BV2 cells found it to be a potential therapeutic target for the treatment of neuroinflammation-associated diseases.

MiR-155/GSK-3β mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-κB signaling pathway in LPS-induced RAW264.7 cell

It is revealed that CsIVa suppresses LPS-triggered immune response by miR-155/GSK-3β-NF-κB signaling pathway and improves the inflammatory response in L PS-induced RAW264.7 cells.

MiR-155-5p Aggravated Astrocyte Activation and Glial Scarring in a Spinal Cord Injury Model by Inhibiting Ndfip1 Expression and PTEN Nuclear Translocation

MiR-155-5p aggravated astrocyte activation and glial scarring in a SCI model by targeting Ndfip1 expression and inhibiting PTEN nuclear translocation and these findings have ramifications for the development of miRNAs as SCI therapeutics.

Mir-155 knockout protects against ischemia/reperfusion-induced brain injury and hemorrhagic transformation

It is found that miR-155 was significantly upregulated after cerebral I/R in wild type mice, and miR -155 knockout mice had comparably smaller cerebral infarct size and improved neurological deficits.

Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures

Data identify miR-155 as a novel modulator of microglia Aβ internalization and synaptic pruning, influencing synaptic homeostasis in the setting of AD pathology.

Neutral Sphingomyelinase Inhibition Alleviates LPS-Induced Microglia Activation and Neuroinflammation after Experimental Traumatic Brain Injury

It is demonstrated that nSMase inhibitors attenuate multiple inflammatory pathways associated with microglial activation in vitro and after experimental TBI, suggesting that n SMase inhibitors may represent promising therapeutics agents targeting neuroinflammation.

Selenium protects against LPS-induced MC3T3-E1 cells apoptosis through modulation of microRNA-155 and PI3K/Akt signaling pathways

It is demonstrated that selenium exerts a cytoprotective effect by attenuating cell apoptosis and oxidative damage via a PI3K/Akt/miR-155-dependent mechanism.

Role of lncRNA Xist-miR-124-CCL2 axis in HIV Tat-mediated microglial activation and neuroinflammation

A novel regulatory axis whereby HIV Tat-induced upregulation of lncRNA Xist sponges miR-124 leads to CCL2 overexpression and microglial activation is identified, leading to CCL2 overexpression and microglial activation.

Intranasal Delivery of miR-155-5p Antagomir Alleviates Acute Seizures Likely by Inhibiting Hippocampal Inflammation

It is demonstrated that intranasal delivery of miR-155-5p antagomir alleviated acute seizures, likely by blocking hippocampal inflammation.

43 References

miR‐155 modulates microglia‐mediated immune response by down‐regulating SOCS‐1 and promoting cytokine and nitric oxide production

Results show that miR‐155 has a pro‐inflammatory role in microglia and is necessary for the progression of the immune response through the modulation of SOCS‐1, suggesting that, in a chronic inflammatory context, miR •155 inhibition can have a neuroprotective effect.

Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia

Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia.

Results demonstrate a potent suppressive effect of resveratrol on proinflammatory responses of microglia, suggesting a therapeutic potential for this compound in neurodegenerative diseases accompanied by microglial activation.

MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis

It is reported here that miR-155 is up-regulated insynovial membrane and synovial fluid (SF) macrophages from patients with rheumatoid arthritis, and miR–deficient mice are resistant to collagen-induced arthritis, with profound suppression of antigen-specific Th17 cell and autoantibody responses and markedly reduced articular inflammation.

Species-specific microRNA roles elucidated following astrocyte activation

The data suggests that miRNA function is more significant in the mechanisms governing astrocyte activation in rodents compared to primates, and identifies subsets of differentially expressed miRNAs some of which are shared with other immunological related systems while others, surprisingly, are mouse and rat specific.

The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis

It is demonstrated that microRNA-155 (Mir-155) expression is elevated in CD4+ T cells during EAE, and Mir-155−/− mice had a delayed course and reduced severity of disease and less inflammation in the CNS, and anti–Mir- 155 treatment reduced clinical severity of EAE when given before and after the appearance of clinical symptoms.

MicroRNA-155 as a proinflammatory regulator via SHIP-1 down-regulation in acute gouty arthritis

Overexpression of miR-155 in the gouty SFMC leads to suppress SHIP-1 levels and enhance proinflammatory cytokines, such as TNF-α and IL-1β.

miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice

Sphingosine-1-phosphate receptor 1 (S1PR1) was found as a new target gene of miR-155 by in vitro and in vivo studies; its expression was decreased in SLE patients and Faslpr/lpr mice.

Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice.

It is demonstrated that miR-155 is essentially involved in the adaptive and innate immune reactions leading to autoimmune arthritis, and therefore mi R-155 might provide a novel target for the treatment of patients with RA.